Horizon Wealth Management’s Boeing BA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.06M Hold
10,332
0.3% 41
2025
Q4
$2.24M Buy
10,332
+8,925
+634% +$1.84M 0.35% 33
2025
Q3
$304K Sell
1,407
-1,925
-58% -$434K 0.04% 96
2025
Q2
$698K Sell
3,332
-2,065
-38% -$390K 0.12% 46
2025
Q1
$920K Buy
5,397
+1,073
+25% +$186K 0.16% 35
2024
Q4
$765K Buy
4,324
+1,000
+30% +$157K 0.13% 38
2024
Q3
$505K Buy
3,324
+972
+41% +$167K 0.1% 47
2024
Q2
$428K Buy
2,352
+1,247
+113% +$222K 0.1% 44
2024
Q1
$213K Sell
1,105
-6,027
-85% -$1.24M 0.06% 75
2023
Q4
$1.86M Buy
7,132
+1,254
+21% +$268K 0.52% 22
2023
Q3
$1.13M Sell
5,878
-17
-0.3% -$3.72K 0.45% 22
2023
Q2
$1.24M Sell
5,895
-54
-0.9% -$11.2K 0.49% 22
2023
Q1
$1.26M Buy
+5,949
New +$1.24M 0.95% 15
2022
Q3
Sell
-28,950
Closed -$3.96M 74
2022
Q2
$3.96M Buy
28,950
+5,609
+24% +$827K 1.64% 18
2022
Q1
$4.47M Buy
23,341
+493
+2% +$99K 1.39% 20
2021
Q4
$4.6M Buy
+22,848
New +$4.83M 1.34% 18

Other funds holding BA

Horizon Wealth Management's BA Position: Q1 2026 in Review

Horizon Wealth Management held its Boeing (BA) position steady in Q1 2026 at 10,332 shares worth $2.06M. The position accounts for 0.3% of the portfolio, ranked #41.

Horizon Wealth Management first reported a position in BA in Q4 2021 and has held it in 16 quarters since. The position peaked at $4.6M in Q4 2021. 2,510 funds tracked by Wall St. Rank hold BA as of Q1 2026.

  • Horizon Wealth Management held 10,332 shares of Boeing worth $2.06M as of Q1 2026.
  • Horizon Wealth Management left its Boeing share count unchanged in Q1 2026.
  • Boeing made up 0.3% of Horizon Wealth Management's portfolio in Q1 2026, its #41 holding.
  • Horizon Wealth Management first reported a position in Boeing in Q4 2021 and has held it in 16 quarters since.
  • Horizon Wealth Management's Boeing position peaked at $4.6M in Q4 2021.
  • 2,510 funds tracked by Wall St. Rank held Boeing as of Q1 2026.

Based on Horizon Wealth Management's 13F filing for Q1 2026, filed 24 Apr 2026.